SMTL ID : 3ddp.1 (1 other biounit)

Structure of phosphorylated Thr160 CDK2/cyclin A in complex with the inhibitor CR8

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

hetero-1-1-mer

Ligands

1 x RC8: (2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol(Non-covalent)

RC8.1: 20 residues within 4Å: Chain A: E.9, K.10, I.11, G.12, E.13, G.14, V.19, A.32, V.65, F.81, E.82, F.83, L.84, H.85, Q.86, Q.132, N.133, L.135, A.145, D.146 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:E.9, A:I.11, A:V.19, A:A.32, A:V.65, A:F.81, A:F.81, A:F.83, A:A.145, A:D.146 Hydrogen bonds: A:E.13, A:G.14, A:L.84, A:L.84

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bettayeb, K. et al., CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases. Oncogene (2008)

Release Date

2008-07-22

Peptides

Cell division protein kinase 2: A
Cyclin-A2: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
D

Cell division protein kinase 2

Cyclin-A2

Related Entries With Identical Sequence